Zimmer Biomet Holdings (ZBH) EPS (Diluted) Growth (3y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 63.42% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 29.56% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 30.57% |
| 10 | Zimmer Biomet Holdings | 17.99 Bn | 17.57 Bn | 1.51 Bn | 3.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.24% |
| Mar 31, 2025 | 73.97% |
| Dec 31, 2024 | -168.00% |
| Sep 30, 2024 | 159.99% |
| Jun 30, 2024 | 378.99% |
| Mar 31, 2024 | 234.65% |
| Dec 31, 2023 | 1.07% |
| Sep 30, 2023 | -13.08% |
| Jun 30, 2023 | 44.12% |
| Mar 31, 2023 | 34.78% |
| Mar 31, 2022 | -30.72% |
| Dec 31, 2021 | 68.33% |
| Sep 30, 2021 | -28.06% |
| Jun 30, 2021 | -26.25% |
| Mar 31, 2021 | -70.39% |
| Dec 31, 2020 | 39.67% |
| Sep 30, 2020 | 34.57% |
| Jun 30, 2020 | -46.03% |
| Mar 31, 2020 | -54.29% |
| Dec 31, 2019 | 81.63% |